Fycompa Tablet
Product Images NDC 62856-276
Product Visual Gallery
This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Fycompa (NDC 62856-276). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eisai Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Median Percent Reduction In Seizure Frequency Per 28 Days From Baseline To Treatment Period (Fycompa 02)
Figure 2. Proportion Of Patients Exhibiting Different Percent Reductions During The Maintenance Phase Over Baseline Across All Three Trials. (Fycompa 03)
Figure 3. Proportion Of Patients Exhibiting Different Percent Reductions During The Maintenance Phase Over Baseline In Primary Generalized Tonic-clonic Seizure Frequency. (Fycompa 04)
Figure A (Fycompa 05)
Figure B (Fycompa 06)
Figure C (Fycompa 07)
Figure D (Fycompa 08)
Figure E (Fycompa 09)
Figure F (Fycompa 0a)
Figure G (Fycompa 0b)
Figure H (Fycompa 0c)
Figure I (Fycompa 0d)
Figure J (Fycompa 0e)
Figure K (Fycompa 0f)
Principal Display Panel (2 mg TabletNDC 62856-272-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII2 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Principal Display Panel (2 mg TabletNDC 62856-272-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII2 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Ndc 62856-272-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii2 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 12)
Principal Display Panel (2 mg TabletNDC 62856-272-1414 tabletsRx onlyFycompa(perampanel) tabletsCIII2 mg2 week sample Kit)
Principal Display Panel (2 mg TabletNDC 62856-272-1414 tabletsRx onlyFycompa(perampanel) tabletsCIII2 mg2 week sample Kit)
Principal Display Panel (2 mg TabletNDC 62856-272-1414 tabletsRx onlyFycompa(perampanel) tabletsCIII2 mg2 week sample Kit)
Principal Display Panel (2 mg TabletNDC 62856-272-1414 tabletsRx onlyFycompa(perampanel) tabletsCIII2 mg2 week sample Kit)
Principal Display Panel (4 mg TabletNDC 62856-274-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII4 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Principal Display Panel (4 mg TabletNDC 62856-274-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII4 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Ndc 62856-274-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii4 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 19)
Principal Display Panel (4 mg TabletNDC 62856-274-1414 tabletsRx onlyFycompa(perampanel) tabletsCIII4 mg2 week sample Kit)
Principal Display Panel (4 mg TabletNDC 62856-274-1414 tabletsRx onlyFycompa(perampanel) tabletsCIII4 mg2 week sample Kit)
Principal Display Panel (6 mg TabletNDC 62856-276-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII6 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Principal Display Panel (6 mg TabletNDC 62856-276-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII6 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Ndc 62856-276-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii6 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 1e)
Principal Display Panel (8 mg TabletNDC 62856-278-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII8 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient)
Principal Display Panel (8 mg TabletNDC 62856-278-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII8 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient)
Ndc 62856-278-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii8 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient (Fycompa 21)
Principal Display Panel (10 mg TabletNDC 62856-280-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII10 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Principal Display Panel (10 mg TabletNDC 62856-280-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII10 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Ndc 62856-280-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii10 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 24)
Principal Display Panel (12 mg TabletNDC 62856-282-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII12 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Principal Display Panel (12 mg TabletNDC 62856-282-3030 tabletsRx onlyFycompa™(perampanel)tabletsCIII12 mgATTENTION PHARMACIST:Dispense the accompanyingMedication Guide to each patient.)
Ndc 62856-282-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii12 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 27)
Ndc 62856-290-380.5 mg/mlrx Onlyfycompa®(perampanel)oral Suspensionciii340 mL (Fycompa 28)
Ndc 62856-290-380.5 mg/mlrx Onlyfycompa®(perampanel)oral Suspensionciii340 mL (Fycompa 29)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.